Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Niesvizky, Ruben; Badros, Ashraf Z.; Costa, Luciano J. et al.
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myelomaLEUKEMIA & LYMPHOMA. Bd. 56. H. 12. 2015 S. 3320-3328
Eberhardt, Wilfried Ernst Erich; Poettgen, Christoph; Gauler, Thomas Christoph et al.
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 35. 2015 S. 4194-+
Mai, E. K.; Bertsch, U.; Duerig, J. et al.
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myelomaLEUKEMIA. Bd. 29. H. 8. 2015 S. 1721-1729
Siebenhofer, Andrea; Plath, Jasper; Taubenroth, Maja et al.
Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional studyBMC CANCER. Bd. 15. 2015
Versluis, Jurjen; Hazenberg, Carin L. E.; Passweg, Jakob R. et al.
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysisLANCET HAEMATOLOGY. Bd. 2. H. 10. 2015 S. E427-E436
Battista, M; Stickeler, E; Schmidt, M
Prädiktive Faktoren bei gynäkologischen TumorenDer Gynäkologe. Bd. 48. 2015 S. 865-870
Battista, M; Stickeler, E; Schmidt, M
Prädiktive Faktoren in der metastasierten SituationDer Gynäkologe. Bd. 48. 2015 S. 885-890
Goetze, Heide; Ernst, Jochen; Braehler, Elmar et al.
Predictors of quality of life of cancer patients, their children, and partnersPSYCHO-ONCOLOGY. Bd. 24. H. 7. 2015 S. 787-795
Schmidt, Marcus; van de Sandt, Leonie; Almstedt, Katrin et al.
Prognostic significance of Focal Adhesion Kinase (FAK) in node-negative breast cancer.JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Schmidt, Marcus; van de Sandt, Leonie; Edlund, Karolina et al.
Prognostic significance of the interferon metagene in node-negative breast cancer depends on the molecular subtypeCANCER RESEARCH. Bd. 75. H. 9. 2015